986 related articles for article (PubMed ID: 18377304)
1. Cerebrospinal fluid eosinophilia in children with ventricular shunts.
Fulkerson DH; Boaz JC
J Neurosurg Pediatr; 2008 Apr; 1(4):288-95. PubMed ID: 18377304
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
[TBL] [Abstract][Full Text] [Related]
3. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection.
Fulkerson DH; Sivaganesan A; Hill JD; Edwards JR; Shoja MM; Boaz JC; Jea A
J Neurosurg Pediatr; 2011 Dec; 8(6):613-9. PubMed ID: 22132920
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus.
Fulkerson DH; Vachhrajani S; Bohnstedt BN; Patel NB; Patel AJ; Fox BD; Jea A; Boaz JC
J Neurosurg Pediatr; 2011 Feb; 7(2):147-51. PubMed ID: 21284459
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.
Arnell K; Cesarini K; Lagerqvist-Widh A; Wester T; Sjölin J
J Neurosurg Pediatr; 2008 May; 1(5):366-72. PubMed ID: 18447670
[TBL] [Abstract][Full Text] [Related]
6. Cerebro-spinal fluid eosinophilia in shunt infections.
Vinchon M; Vallee L; Prin L; Desreumaux P; Dhellemmes P
Neuropediatrics; 1992 Oct; 23(5):235-40. PubMed ID: 1454141
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticosteroid treatment for cerebrospinal fluid eosinophilia in a patient with ventriculoperitonial shunt.
Tangsinmankong N; Nelson RP; Good RA
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):341-2. PubMed ID: 10541427
[TBL] [Abstract][Full Text] [Related]
8. Postoperative cerebrospinal fluid wound leakage as a predictor of shunt infection: a prospective analysis of 205 cases. Clinical article.
Jeelani NU; Kulkarni AV; Desilva P; Thompson DN; Hayward RD
J Neurosurg Pediatr; 2009 Aug; 4(2):166-9. PubMed ID: 19645552
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid eosinophilia associated with intraventricular shunts.
Bezerra S; Frigeri TM; Severo CM; Santana JC; Graeff-Teixeira C
Clin Neurol Neurosurg; 2011 Jun; 113(5):345-9. PubMed ID: 21492998
[TBL] [Abstract][Full Text] [Related]
10. Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts.
Tung H; Raffel C; McComb JG
J Neurosurg; 1991 Oct; 75(4):541-4. PubMed ID: 1885971
[TBL] [Abstract][Full Text] [Related]
11. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of factors influencing cerebrospinal fluid shunt survival in infants and children.
Shah SS; Hall M; Slonim AD; Hornig GW; Berry JG; Sharma V
Neurosurgery; 2008 May; 62(5):1095-102; discussion 1102-3. PubMed ID: 18580807
[TBL] [Abstract][Full Text] [Related]
13. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
14. Shunt infection: is there a near-miss scenario?
Thompson DN; Hartley JC; Hayward RD
J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
[TBL] [Abstract][Full Text] [Related]
16. Management of shunt infections: a multicenter pilot study.
Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial.
Rozzelle CJ; Leonardo J; Li V
J Neurosurg Pediatr; 2008 Aug; 2(2):111-7. PubMed ID: 18671615
[TBL] [Abstract][Full Text] [Related]
18. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
Willis BK; Kumar CR; Wylen EL; Nanda A
Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
[TBL] [Abstract][Full Text] [Related]
19. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
[TBL] [Abstract][Full Text] [Related]
20. The value of C-reactive protein in the management of shunt infections.
Schuhmann MU; Ostrowski KR; Draper EJ; Chu JW; Ham SD; Sood S; McAllister JP
J Neurosurg; 2005 Sep; 103(3 Suppl):223-30. PubMed ID: 16238075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
